| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |